Dr. Chiba-Falek participated as a panelist in the Alzheimer’s Association Business Consortium (AABC) Panel at the AAIC 2022 for a discussion on Therapeutic targets & strategies in Alzheimer’s disease Jul 2022
CLAIRIgene welcome Dr. Hamm to the leadership team to lead the business development of the company. Jun 2022
Dr. Chiba-Falek joined Susan Ryan, a senior director at The Green House Project, to the episode “Editing the genetics of Alzheimer’s” in the podcast series “Elevate Eldercare” to discuss her groundbreaking work, and what it could eventually mean for families and caregivers. Feb 2022Click at the link, to listen to the podcast broadcasted on February 9, 2022 Green House Podcast: Elevate Eldercare – Green House Project (thegreenhouseproject.org)
CLAIRIgene was awarded a SRA from Seelos Therapeutics for a research project entitled: “Neuronal-type specific gene therapy for dementia with Lewy Body” Aug 2021
CLAIRIgene was awarded a SRA from Seelos Therapeutics for a research project entitled: “Modeling of neurodegenerative diseases via an all-in-one bimodal lentiviral vector” Jun 2020
